Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Etzler Todd A.Executive Vice President & GC | Tax withholding | F | $4,587 292 sh | Mar 20, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 506.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 638.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 181.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Neagle MatthewChief Operating Officer | Option exercise | M | — 826.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Grant or award | A | — 103.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 20.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 21.2K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Mutschink John M.EVP, Chief Admin Officer | Tax withholding | F | $25K 635 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Shlimak AnnaSee Remarks | Tax withholding | F | $25K 9,767 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 638.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,699 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 30.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 543.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Statham JamiSVP, General Counsel | Tax withholding | F | $5,406 4,395 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 375.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 125.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | dMY Squared Sponsor, LLCDirector, 10% Owner | Derivative conversion | C | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Tax withholding | F | $1,849 1,249 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 20.0K sh | Mar 20, 2026 traded Mar 19, 2026 |